CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net loss	$ (1,498)	$ (1,401)	$ (4,449)	$ (4,835)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation	53	72	101	144
Amortization of intangible assets	131	231	292	491
Amortization of capitalized software development costs			167	167
Amortization of deferred financing costs			15	7
Amortization of debt discount			556	482
Loss on debt settled in shares			145	0
Stock-based compensation expense			531	1,101
Credit loss expense	(2)	97	30	97
Change in fair value of derivative instruments, net			(240)	(114)
Foreign currency transaction (gain) loss			135	187
Deferred income taxes			6	77
Changes in assets and liabilities:
Contract receivables, net			(254)	1,578
Prepaid expenses and other assets			1,472	3,020
Accounts payable, accrued compensation and accrued expenses			1,724	379
Billings in excess of revenue earned			(992)	(588)
Accrued warranty			(72)	(138)
Other liabilities			10	(416)
Net cash (used in) provided by operating activities			(823)	1,639
Cash flows from investing activities:
Capital expenditures			(13)	(134)
Capitalized software development costs			(239)	(206)
Net cash used in investing activities			(252)	(340)
Cash flows from financing activities:
Repayment of line of credit			0	(1,817)
Repayment of insurance premium financing			(486)	(594)
Proceeds from issuance of long-term debt and warrants			1,800	5,750
Payments of debt issuance and original discount on issuance of long-term debt and warrants			(386)	(968)
Principal repayment of convertible note			(768)	0
Tax paid for shares withheld			(77)	(203)
Net cash provided by financing activities			83	2,168
Effect of exchange rate changes on cash			(29)	(70)
Net (decrease) increase in cash, cash equivalents and restricted cash			(1,021)	3,397
Cash, cash equivalents and restricted cash at beginning of the period			4,376	3,550
Cash, cash equivalents and restricted cash at the end of the period	3,355	6,947	3,355	6,947
Cash and cash equivalents	1,775	5,364	1,775	5,364
Restricted cash, current	500	632	500	632
Restricted cash included in other long-term assets	1,080	951	1,080	951
Total cash, cash equivalents and restricted cash	3,355	6,947	3,355	6,947
Non-cash financing activities
Repayment of convertible note in shares			1,293	0
Establishment of new right-of-use assets			1,294	0
Establishment of new operating lease liability			(333)	0
Discount on issuance of convertible note	$ 300	$ 750	$ 300	$ 750